Analysis of the hypotensive effects of medroxalol and its enantiomers, MDL 17,330A and MDL 17,331A

Clinical and Experimental Hypertension. Part A, Theory and Practice
A A Hancock

Abstract

Medroxalol and two of its enantiomers (MDL 17, 330A , MDL 17, 331A ) were tested for activity at adrenergic receptors to clarify the mechanism(s) of the antihypertensive action of medroxalol . The potency order for blocking postsynaptic alpha 1-receptors in vivo in rats was similar to that reported in vitro. However, relatively high doses of these compounds were necessary to block alpha 1-receptors in vivo compared to their antihypertensive doses. Postsynaptic alpha 2-receptors were not blocked by medroxalol in vitro. Propranolol pretreatment of rats to block vascular beta 2-receptors antagonized much of the hypotensive response to medroxalol and its enantioners , most extensively with MDL 17, 330A , but much less with MDL 17, 331A . The potency rank order as beta 2-adrenergic agonists was the same as previously reported for these compounds as beta 1-adrenergic receptor antagonists. The stimulation of beta 2-adrenergic receptors in vascular smooth muscle appears to be an important factor in the hypotensive action of medroxalol .

References

Oct 1, 1979·British Journal of Pharmacology·G M Drew, S B Whiting
Sep 1, 1978·The American Journal of Physiology·K M BaldwinR E Lewis
Mar 1, 1970·Clinical Pharmacology and Therapeutics·R TabeiA Sjoerdsma
Apr 4, 1980·European Journal of Pharmacology·K SugawaraM Ozaki
Mar 1, 1981·Journal of Cardiovascular Pharmacology·R C DageJ K Woodward

Related Concepts

Medroxalol monohydrochloride, (S-(R*, S*))-isomer
Adrenergic alpha-Antagonists
Adrenergic beta-Antagonists
Metazoa
Antihypertensive Agents
Diastolic Blood Pressure
Isoglaucon
Canis familiaris
Ethanolamines
Norepinephrine, (+, -)-Isomer

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.